XRN · Chiron Real Estate Inc.
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $153.43M | $148.21M | $138.78M | $141.05M | $137.28M | $115.94M | $93.73M | $70.73M | $53.19M | $30.34M | $8.21M | $2.06M | $380.41K | — | — | |
| $150.29M | $147.68M | $138.41M | $140.93M | $137.17M | $115.8M | $93.52M | $70.52M | $53.14M | $30.22M | $8.08M | $2.05M | — | — | — | |
| $20.66M | $20M | $21.12M | $16.85M | $16.55M | $16.45M | $11.94M | $6.54M | $5.54M | $5.49M | $4.22M | $425K | $454.87K | $45.34K | $50.11K | |
| — | — | — | — | — | — | — | — | — | — | — | $659.67K | — | — | — | |
| — | $13.01M | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $129.85M | — | — | $134.01M | $124.04M | $98.66M | $96.23M | $61.14M | $46.31M | $30.43M | $14.56M | $3.67M | $1.03M | $45.34K | $50.11K | |
| $32.62M | $31.75M | $28.69M | $30.89M | $25.23M | $19.7M | $18.68M | $17.47M | $14.98M | $7.44M | $4.14M | $1.52M | $298.66K | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | $0 | |
| $62.73M | -$6.88M | $6.69M | $21.73M | $20M | $18.34M | -$2.5M | $9.59M | $14.56M | -$87K | -$6.35M | -$1.61M | -$652.21K | -$45.34K | -$50.11K | |
| — | -4.64% | 4.82% | 15.41% | 14.57% | 15.82% | -2.67% | 13.56% | 27.37% | -0.29% | -77.37% | -78.03% | -171.45% | — | — | |
| $4.78M | -$1.05M | $59K | $1.12M | $854K | $720K | -$574K | $354K | $1.07M | -$49K | $0 | $0 | — | — | — | |
| $49.12M | -$12.12M | $811K | $14.79M | $13.32M | $11.8M | -$7.75M | $3.41M | $7.67M | -$1.75M | -$6.35M | -$1.61M | — | — | — | |
| $72.47M | — | — | — | — | $29.93M | -$14.04M | $6.64M | $10.84M | -$87K | -$6.35M | — | — | — | — | |
| USD/shares | $3.71 | -$0.91 | $0.06 | $1.13 | $1.00 | $0.95 | -$0.85 | $0.50 | — | — | — | — | — | — | — |
| USD/shares | $3.71 | -$0.91 | $0.06 | $1.13 | $1.00 | $0.95 | -$0.85 | $0.50 | — | — | — | — | — | — | — |
| shares | — | 13.38M | 13.19M | 13.11M | 13.09M | 12.13M | 9.25M | 6.77M | 4.39M | 3.92M | 1.86M | 50K | 9671.2 | 1.57M | 1.1M |
| shares | — | 13.38M | 13.19M | 13.11M | 13.09M | 12.13M | 9.25M | 6.77M | 4.39M | 3.92M | 1.86M | 50K | 9671.2 | 1.57M | — |
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2015–FY2025: $6M in buybacks, $47.32M in dividends.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 8 similar-size REIT - Healthcare Facilities companies (of 17 listed).